Clemens Schulte

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Top Venues

Cell death & disease

Angewandte Chemie (International ed. in English)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 43 (8) (2024)
Marco Gründl, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyss, Stefan Gaubatz
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene (2024)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Thamara Nishida Xavier da Silva, Clemens Schulte, Ariane Nunes Alves, Hans Michael Maric, José Pedro Friedmann Angeli
Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules. Cell death & disease 14 (4) (2023)
Vladimir Khayenko, Clemens Schulte, Sara L Reis, Orly Avraham, Cataldo Schietroma, Rafael Worschech, Noah F Nordblom, Sonja Kachler, Carmen Villmann, Katrin G Heinze, Andreas Schlosser, Ora Schueler-Furman, Philip Tovote, Christian G Specht, Hans Michael Maric
A Versatile Synthetic Affinity Probe Reveals Inhibitory Synapse Ultrastructure and Brain Connectivity. Angewandte Chemie (International ed. in English) 61 (30) (2022)
Carlos Moreno-Yruela, Michael Bæk, Adela-Eugenie Vrsanova, Clemens Schulte, Hans Michael Maric, Christian A Olsen
Hydroxamic acid-modified peptide microarrays for profiling isozyme-selective interactions and inhibition of histone deacetylases. Nature communications 12 (1) (2021)